Mindfulness Training Supports Quality of Life and Advance Care Planning in Adults With Metastatic Cancer and Their Caregivers: Results of a Pilot Study by Johns, Shelley A. et al.
Mindfulness Training Supports Quality of Life and Advance Care Planning
in Adults with Metastatic Cancer and their Caregivers: Results of a Pilot Study 
Short title: Mindfulness Supports Quality of Life 
Shelley A. Johns, PsyD, HSPP, ABPP,1,2,3,4 Kathleen Beck-Coon, MD,1,5 Patrick V. Stutz, BA,1 
Tasneem L. Talib, PhD,2 Kelly Chinh, MS,6 Ann H. Cottingham, MA, MAR,1,2 Karen Schmidt, MSN, CCRP,1 
Cleveland Shields, PhD,7 Madison E. Stout, BS,2 Timothy E. Stump, MA,1 Patrick O. Monahan, PhD,1  
Alexia M. Torke, MD, MS,1,2,3,4 Paul R. Helft, MD,1,3,4,8 
Corresponding Author: Shelley A. Johns, PsyD, HSPP, ABPP [ORCID ID: 0000-0001-5730-1822] 
Address: Regenstrief Institute, Inc., 1101 W 10th St, RF-226, Indianapolis, IN 46202 
Phone: (317) 274-9127 
Email: sheljohn@iu.edu 
__________________________________ 
1Indiana University School of Medicine, Indianapolis, IN 
2Regenstrief Institute, Inc., Indianapolis, IN 
3Charles Warren Fairbanks Center for Medical Ethics, Indianapolis, IN 
4Indiana University-Purdue University Indianapolis RESPECT Center, Indianapolis, IN 
5Indiana University School of Nursing, Indianapolis, IN 
6Indiana University-Purdue University Indianapolis Department of Psychology, Indianapolis, IN 
7Purdue University Department of Human Development and Family Studies, West Lafayette, IN 
8Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 
____________________________________________________
This is the author's manuscript of the article published in final edited form as: 
Johns, S. A., Beck-Coon, K., Stutz, P. V., Talib, T. L., Chinh, K., Cottingham, A. H., Schmidt, K., Shields, C., Stout, M. E., Stump, 
T. E., Monahan, P. O., Torke, A. M., & Helft, P. R. (2020). Mindfulness Training Supports Quality of Life and Advance Care 
Planning in Adults With Metastatic Cancer and Their Caregivers: Results of a Pilot Study. American Journal of Hospice and 
Palliative Medicine®, 37(2), 88–99. https://doi.org/10.1177/1049909119862254
2 
 
ABSTRACT 
Background: Emotional distress often causes cancer patients and their family caregivers (FCGs) to avoid end-of-life 
discussions and advance care planning (ACP), which may undermine quality of life (QoL). Most ACP interventions 
fail to address emotional barriers that impede timely ACP. 
Aim: We assessed feasibility, acceptability, and preliminary effects of a mindfulness-based intervention to facilitate 
ACP for adults with advanced-stage cancer and their FCGs. 
Design: A single-arm pilot was conducted to assess impact of a 6-week group mindfulness intervention on ACP 
behaviors (patients only), QoL, family communication, avoidant coping, distress, and other outcomes from baseline 
(T1) to post-intervention (T2) and 1 month later (T3). 
Participants: Eligible patients had advanced-stage solid malignancies, limited ACP engagement, and a FCG willing 
to participate. Thirteen dyads (N=26 participants) enrolled at an academic cancer center in the United States. 
Results: Of eligible patients, 59.1% enrolled. Attendance (70.8% across 6 sessions) and retention (84.6% for 
patients; 92.3% for FCGs) through T3 were acceptable. Over 90% of completers reported high intervention 
satisfaction. From T1 to T3, patient engagement more than doubled in each of three ACP behaviors assessed. 
Patients reported large significant decreases in distress at T2 and T3. FCGs reported large significant improvements 
in QoL and family communication at T2 and T3. Both patients and FCGs reported notable reductions in sleep 
disturbance and avoidant coping at T3. 
Conclusions: The mindfulness intervention was feasible and acceptable and supported improvements in ACP and 
associated outcomes for patients and FCGs. A randomized trial of mindfulness training for ACP is warranted. The 
study is registered at ClinicalTrials.gov with identifier NCT02367508 (https://clinicaltrials.gov/ct2/show/ 
NCT02367508). 
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MAIN TEXT 
INTRODUCTION 
Discussing diagnosis, prognosis, and treatment goals is essential to the advance care planning (ACP) process, 
whereby individuals indicate care preferences to family and healthcare providers should they become medically 
incapacitated.1 Preferences can be communicated verbally or using advance medical directives, wherein patients put 
into writing the treatments they would or would not want as their disease progresses. Timely ACP has been 
associated with positive outcomes for patients and family caregivers (FCGs), including earlier hospice referral,2 
increased care satisfaction,3 improved preparation for death,4 and reduced complicated grief for FCGs.4,5  
Despite these benefits, approximately half of the 606,000 Americans dying of cancer in 20196 will not have 
end-of-life (EOL) care discussions before the final month of life.7,8 Delaying or avoiding EOL discussions and ACP 
is associated with negative outcomes for patients and FCGs. Patients uninformed about their prognosis are 3-8 times 
more likely to receive non-beneficial treatments in the final week of life,8-10 which may undermine physical and 
emotional quality of life (QoL).11-13 Avoiding EOL discussions and ACP also prevents patients from experiencing 
benefits of palliative care integrated with standard cancer care earlier in the disease course, including improved 
QoL, mood, and survival;14 for FCGs, avoiding EOL discussions and ACP can adversely affect bereavement 
adjustment.15 
A variety of interacting factors contribute to this avoidance.16 Advanced cancer patients vary in their 
willingness to engage in ACP discussions.17 Patients and FCGs typically wait for oncologists to initiate prognosis 
conversations,18 yet most oncologists delay discussions of prognosis, code status, advance medical directives, and 
hospice until the final month of life when many patients are too ill to make complex decisions.19 Patients and FCGs 
may also experience fear or distress surrounding ACP.20,21 To manage distress, patients and FCGs may employ an 
avoidant coping style by refusing to accept medical realities,22 thereby further delaying conversations about disease 
progression.23,24 Given potential negative consequences of avoiding EOL discussions and ACP, interventions that 
reduce maladaptive coping and distress surrounding these conversations are urgently needed. 
One intervention showing promise in palliative care is mindfulness meditation. Mindfulness is a natural 
human capacity characterized by non-judgmental attention to present moment experiences without emotional 
reactivity.25 According to mindfulness theory, individuals who practice mindfulness develop greater self-regulation, 
self-awareness, and self-transcendence in service of enhanced QoL.26 In advanced cancer, mindfulness may promote 
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greater acceptance of medical realities, thereby reducing distress, avoidant coping, and delays in ACP while 
improving overall QoL. 
Emerging research has shown that mindfulness training reduces psychological 27-29 and physical symptoms,30-
34 particularly among post-treatment cancer survivors. Mindfulness has also been shown to buffer reactivity to 
existential threat35 and to reduce avoidant coping.36-39 Although large-scale randomized trials of mindfulness in 
advanced cancer are lacking,40 several pilot studies have demonstrated reduced psychological distress in patients and 
FCGs,41,42 improved patient mental health,43,44 and reduced FCG burden.45 To date, no studies have assessed the 
effects of mindfulness on ACP behaviors among advanced-stage cancer patients and their FCGs. 
 Consistent with the Institute of Medicine’s recommendations for person-centered, family-oriented EOL 
care,1 we developed and pilot tested a mindfulness-based intervention—Mindfully Optimizing Delivery of End-of-
Life Care (MODEL Care)—to support adults with advanced-stage cancer and their FCGs in approaching EOL 
conversations and ACP with greater ease. Our first aim was to assess feasibility and acceptability. Our second aim 
was to assess intervention effect sizes on ACP behaviors (patients only), QoL, family communication, avoidant 
coping, distress, and other outcomes. 
METHODS 
The study was approved by the Scientific Review Committee of the National Cancer Institute-designated Indiana 
University Simon Cancer Center (IUCRO-0460) and corresponding Indiana University Institutional Review Board 
(IRB #1312088151). Written informed consent was obtained in-person from all participants prior to enrollment. 
Eligible patients: (1) were at least 18 years old, (2) were being treated for a stage IIIB, IIIC, or IV solid 
malignancy, (3) had an oncologist-estimated prognosis of less than 12 months,46,47 (4) had a FCG willing to 
participate, (5) were willing to attend 6 weekly 2-hour mindfulness training sessions, (6) had not completed a 
Physician Orders for Scope of Treatment (POST) form, and (7) were able to provide informed consent. Patients 
were excluded if they: (1) had Eastern Cooperative Oncology Group performance status >2,48 or (2) were receiving 
hospice care. FCGs were eligible if they were: (1) at least 18 years old, (2) invited to participate by an eligible 
patient, (3) willing to attend 6 weekly 2-hour mindfulness training sessions, and (4) able to provide informed 
consent. 
Procedures 
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This pilot employed a single-arm design. Recruiters partnered with 4 medical oncologists and 1 oncology nurse to 
identify potentially eligible patients on their panel with clinic appointments in the 6-week recruitment period 
preceding the start of the intervention. All identified patients and FCGs were approached during clinic appointments 
or via telephone and were systematically screened for eligibility. 
Using mail or online surveys, quantitative self-reported data were collected from dyads at baseline (T1), 
immediately post-intervention (T2), and 1 month post-intervention (T3). Qualitative interviews were conducted after 
T2, results of which are reported elsewhere.49 Participants earned a $25 gift card for each of the three completed 
quantitative surveys and the qualitative interview. 
Intervention 
Two cohorts of 6-7 dyads met as a group for 6 weekly, 2-hour experiential sessions led by a certified mindfulness 
facilitator with extensive training in mindfulness-based teaching methods from the Center for Mindfulness at the 
University of Massachusetts. The intervention was modeled after the Mindfulness-Based Stress Reduction 
program50 and featured formal mindfulness meditation training (i.e., body scan, sitting meditation, gentle hatha 
yoga, compassion meditation). Emphasis was placed on embodying interpersonal mindfulness in dialogue.51 
Practices were designed to (1) cultivate adaptive, non-reactive, and non-judgmental awareness of thoughts, feelings, 
and bodily sensations in everyday life, and (2) be accessible and adaptable for those who were physically weak or 
severely ill. For example, if awareness of breath proved too difficult for a participant with dyspnea, attention was 
focused on other bodily sensations (e.g., feet on the floor, ice chips on the tongue). For patients unable to stand, 
chair adaptations for yoga were taught in tandem with standing yoga practices. In addition, simple stretching options 
for home practice in bed were modeled in class with the teacher lying on the floor for added visual learning. 
Participants were encouraged to complete formal mindfulness practices using audio recordings of practices covered 
in class for 20 minutes per day, 6 days per week. 
ACP was introduced in Session 4. Specific ACP tools were provided, including the POST form,52 with 
guidance on appropriate use. To supplement discussion, participants also received a copy of the American Society of 
Clinical Oncology’s ACP decision-making booklet.53 Class discussion explicitly honored the variety of beliefs and 
values expressed in group, including informed refusal of ACP. See Table 1 for a summary of each session and the 
intervention’s core components. 
Measures 
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Demographic and clinical characteristics were collected from participants at T1 (see Table 2). Feasibility and 
acceptability were measured using accrual, attendance, and retention rates through T3; participants’ responses to 
satisfaction and helpfulness items at T2; and participants’ responses to home practice engagement questions at T2 
and T3.  
Preliminary Efficacy. All selected outcome measures are valid, reliable, and have routinely been used in 
cancer care research. Patients reported ACP engagement at T1 and T3 across three behaviors: (1) having completed 
a POST form with a physician, (2) having discussed goals of care with their oncologist, and (3) having discussed 
goals of care with family.54 Patients also indicated their stage of change55 or readiness for completing each behavior 
by selecting responses ranging from “have not thought about it or not ready to complete” (Precontemplation), 
“thinking about completing in the next 6 months” (Contemplation), or “planning to complete in the next 30 days” 
(Preparation); if the ACP behavior was already completed, patients indicated time of completion, either “in the last 6 
months” (Action) or “more than 6 months ago” (Maintenance). To assess family communication, participants 
completed the Openness to Discuss Cancer in the Nuclear Family (ODCNF) scale.56 Patient QoL was measured with 
the McGill Quality of Life Inventory total score57 while FCGs completed the Caregiver Quality of Life Index-
Cancer [CQoLI-C] scale.58 Avoidant coping was measured with the cognitive avoidance subscale of the Mini-Mental 
Adjustment to Cancer Scale [Mini-MAC]59 and the self-distraction, denial, and behavioral disengagement subscales 
from the Brief COPE.60 To assess distress, participants responded to measures of depression (Patient Health 
Questionnaire [PHQ-8])61 and anxiety (Generalized Anxiety Disorder scale [GAD-7]).62 Sleep disturbance was 
assessed with a single item from the Pittsburgh Sleep Quality Index [PSQI].63 Fatigue interference was assessed 
with the interference subscale of the Fatigue Symptom Inventory [FSI].64,65 
Data Analysis 
Descriptive statistics were computed on demographic and clinical characteristics. Feasibility benchmarks included: 
(1) at least 50% of eligible dyads enrolling in the study, and (2) attendance rates of 70% or greater across the 6 
sessions. Acceptability benchmarks included: (1) at least 70% of participants completing the study,66 and (2) at least 
70% of participants reporting being mostly to completely satisfied with their intervention experience. The 
standardized response mean (SRM) effect size was calculated to assess magnitude of intervention effects at T2 and 
T3 for patients and FCGs separately. To determine SRM, mean change in T2 and T3 scores relative to T1 was 
calculated and divided by the standard deviation of change. For 95% confidence intervals (CIs), we computed an 
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SRM statistic for each participant (participant’s mean change divided by the sample’s SD of change scores). Then, 
we used the SAS MEANS procedure with the LCLM and UCLM options to compute the lower and upper 95% 
confidence limits for the SRM statistic. The primary efficacy-related goal of this pilot was to estimate effect sizes; 
however, preliminary hypothesis tests were also performed. The two-sided paired t-test was used to determine 
significant (p < 0.05) responsiveness over time. Due to the small sample, marginal significance (0.05 < p < 0.10) 
was also reported. SRMs of 0.2, 0.5, and 0.8 indicated small, medium, and large effect sizes, respectively.67 Effect 
sizes of at least half a SD (≥ 0.50) are considered clinically meaningful.68-69 
RESULTS 
Demographic and Clinical Characteristics  
Demographic and clinical characteristics of the 13 dyads are shown in Table 2. About half of the patients were male 
(53.9%), and the majority of FCGs were female (76.9%). FCGs were spouses (69.2%), adult children (23.1%), or 
family friends (7.7%) of the patient. Patients had varying cancer types and were diagnosed with advanced-stage 
cancer an average of 20.9 months (SD=21.4) before enrollment. 
Feasibility and Acceptability  
Over 6 weeks, 64 patients were approached with 43 (67.2%) assessed for eligibility (see Figure 1). Of those 
assessed, 22 (51.2%) were eligible and 13 (59.1%) enrolled in the study. The mean number of sessions attended was 
4.3 for patients and 4.2 for FCGs. Most participants missing a session completed a brief make-up session by phone 
with the facilitator. One dyad withdrew after Session 1 and one patient died between T2 and T3, resulting in 
retention rates of 84.6% for patients and 92.3% for FCGs at T3. Notably, 91.3% of participants reported being 
mostly to completely satisfied with their MODEL Care experience, with the modal response being “completely 
satisfied.” Most participants rated the number and length of sessions as "about right" (91.3% and 87.5%, 
respectively). Table 3 summarizes additional acceptability items. 
Intervention Effects  
Table 4 shows intervention effects for patients and FCGs. At T2, patients showed a statistically significant, large 
reduction in depression (SRM=-0.91, p=0.01) and a marginally significant, medium reduction in cognitive 
avoidance (SRM=-0.64, p=0.059). Furthermore, medium effect sizes were observed for improved anxiety (SRM=-
0.49), sleep disturbance (SRM=-0.54), behavioral disengagement (SRM=-0.54), and QoL (SRM=0.49). FCGs 
reported significant, large improvements in QoL (SRM=0.85, p=0.01) and family communication (SRM=0.88, 
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p=0.01) and marginally significant, medium reductions in anxiety (SRM=-0.58, p=0.069), fatigue interference 
(SRM=-0.56, p=0.079), and cognitive avoidance (SRM=-0.53, p=0.094). 
At T3, effects were generally maintained or strengthened. Patients showed large, statistically significant 
improvements in depression (SRM=-1.38, p=0.001), anxiety (SRM=-0.83, p=0.02), sleep disturbance (SRM=-0.79, 
p=0.025), self-distraction (SRM=-0.91, p=0.013), behavioral disengagement (SRM=-0.79, p=0.026), and QoL 
(SRM=0.95, p=0.010). For FCGs, the large and significant effects on QoL (SRM=1.02, p=0.007) and family 
communication (SRM=0.80, p=0.025) were maintained and a large, significant effect on reduced cognitive 
avoidance (SRM=-1.05, p=0.004) emerged. In addition, a marginally significant reduction in sleep disturbance was 
observed with a medium-to-large effect size (SRM=-0.71, p=0.052). 
Regarding ACP stages of change from T1 to T3, 90% of patients progressed at least one stage of readiness 
to complete a POST form. Of those not already in Action or Maintenance stages at T1 for having a goals of care 
conversation with their oncologist, 100% of responding patients progressed at least 2 stages of readiness for this 
behavior at T3, while 75% progressed at least 1 stage on having a goals of care conversation with their family 
members (see Figure 2). As shown in Figure 3, patients reported marked progress across the three ACP behaviors 
assessed. Patients reported statistically-significant progress in having conversations about goals of care with their 
oncologists (p=0.03), with non-significant trends for having goals of care conversations with family members 
(p=.06) and completing a POST form (p=.06). 
DISCUSSION 
This pilot of mindfulness training in dyads of advanced cancer patients and FCGs has several important findings. 
First, a 6-week mindfulness training program is feasible and highly acceptable among this population. Second, 
preliminary effects suggest mindfulness training may significantly reduce symptoms associated with advanced-stage 
cancer while promoting ACP behaviors, with several results being both statistically significant and clinically 
meaningful.68-69 Lastly, these improvements were sustained at least 1 month post-intervention. Despite a small 
sample size, efficacy tests generally showed statistically significant efficacy for the outcomes that demonstrated 
large effect sizes and marginally significant efficacy for outcomes that demonstrated medium effect sizes. In fact, 
our sample of 12 individuals with both T1 and either T2 or T3 scores provides only 35% and 71% power, 
respectively, to detect medium (0.50) and large (0.80) effect sizes in standardized mean change scores using the 
two-sided paired t-test with 0.05 alpha. When alpha of 0.10 is used for assessing marginal significance, the power 
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for 0.50 and 0.80 effect sizes is 49% and 82%, respectively, for a sample of size 12, and 46% and 79% for a sample 
size of 11.  
Our findings suggest that participants are open to mindfulness training and are willing to complete a multi-
session program. Over half of eligible patients enrolled with their FCGs, demonstrating notable openness to engage 
in mindfulness training late in the disease course. Sustained commitment and engagement were further exemplified 
by relatively high attendance, retention, and participant-reported formal and informal mindfulness practice at home, 
even after the intervention period. With more than 90% of completers reporting being mostly or completely satisfied 
with MODEL Care, mindfulness training was perceived as an acceptable intervention by this population. While 
many patients with cancer are uncomfortable thinking or talking about EOL,20,21,70 our recruitment, enrollment, 
attendance, and retention rates suggest patients and FCGs, even those with limited ACP engagement before 
enrollment, are eager to engage in training that may help them overcome barriers to ACP. 
Mindfulness has long been shown to improve mental health outcomes,27-29 physical symptoms,30-34 and 
QoL71,72 in adults with cancer, and our findings are consistent with other studies.41,42 Patients and FCGs reported 
notable reductions in distress and avoidant coping after 6 weeks of mindfulness training and 1 month later; given 
that distress and avoidant coping may interfere with initiating EOL discussions, minimizing these barriers is a 
logical first step toward facilitating ACP behaviors among this patient population. Participants also reported 
improved QoL at T2 compared to T1 with increasing improvements at T3; this is a meaningful finding for a sample 
of patients with progressive cancer, whose QoL tends to decrease approaching EOL. 
To our knowledge, this is the first study to test the effects of mindfulness training on ACP behaviors in 
adults with advanced cancer. Our exploratory findings suggest mindfulness training may help improve ACP 
engagement, evidenced not only by significantly increased completion of ACP behaviors from T1 to T3, but also 
through patients’ rapid progression in readiness to engage. Mindfulness may promote emotional regulation73 such 
that ACP behaviors may be completed with greater ease and less emotional reactivity. Mindfulness may also 
facilitate greater psychological flexibility (i.e., ability to connect with present-moment experiences to accept realities 
of one’s diagnosis and prognosis) leading to increased engagement in ACP process. By promoting present-moment 
awareness, nonjudgmental acceptance, and emotional regulation,74 mindfulness training may facilitate earlier EOL 
decision-making while patients still have the capacity to make medical decisions and articulate their preferences. 
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Several limitations of the current study should be noted. We used a single-arm design, which limits our 
ability to conclude that improved outcomes were due to MODEL Care. Other extraneous factors (e.g., passage of 
time) could have contributed to the observed changes. The small sample size of 13 dyads and correspondingly wide 
CIs on most outcomes also limit the strength of our conclusions; however, the majority of outcome effect sizes for 
patients and FCGs were ≥ 0.40, supporting further testing of mindfulness in this population. Participants also 
reported low distress levels, as evidenced by non-clinically significant PHQ-8 and GAD-7 group mean scores61,62 at 
every time point. Finally, most participants were English-speaking, Caucasian, and reported having a comfortable 
income, thereby limiting generalizability outside of these demographics. Due to our nonrandomized, single-arm 
design, participants knew they would receive a dyadic mindfulness-based group intervention before enrolling. It is 
possible that only those interested in this approach and format enrolled in the study, which may limit generalizability 
to those not interested in mindfulness or a dyadic, group-based intervention. 
Nonetheless, results of this pilot suggest that mindfulness training could play a useful role in improving and 
expanding ACP uptake by preparing patients and FCGs to discuss the emotionally challenging subject of EOL with 
greater ease. Despite ongoing efforts to increase ACP, a recent longitudinal study found no increase in EOL 
discussions or use of living wills among those with cancer over a 12-year period.75 Thus, determining definitive 
effects of mindfulness training on ACP is essential. Future work should test the efficacy of MODEL Care in a 
randomized controlled trial in comparison with standard care or another established ACP intervention (e.g., 
Respecting Choices).76 
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TABLES 
Table 1.  MODEL Care Intervention Summary.a 
 
 Session Theme 
Mindfulness 
Practices Didactics Home Practice 
1  
Awareness:  
Meeting 
ourselves 
where we are 
in honesty and 
kindness 
 Mindful eating 
(raisin 
exercise) 
 Body scan 
(focusing on 
awareness of 
breath and 
body 
sensations)  
 Course introduction and guidelines. 
 Defining mindfulness as being present for our lives 
just as they are. Mindfulness as a means for 
enhancing connection with those we love, 
identifying what is important to us, and enabling us 
to choose to proceed from personal values rather 
than emotional reactions.    
 Introduction of interpersonal mindful dialogue skills, 
including listening attentively with curiosity and 
non-judgment, without needing to give advice or 
comment on others’ sharing.  
 Body scan daily  
 Eat one meal 
mindfully  
 Mindfulness of one 
daily activity  
2  
Perception 
and creative 
responding: 
Struggle 
against “life as 
it is” as a 
source of 
suffering; 
wholeness no 
matter what’s 
here 
 Body scan 
 Introduction of 
gentle hatha 
yoga 
stretching 
 Awareness of 
breath 
(AOB) 
sitting 
meditation  
 Role of perception, habit-driven conditioning, and 
other mental factors in the self-appraisal of stress.   
 Recognizing with kindness, struggle as it is reflected 
in the body.  
 Use of mindfulness to enhance comfort in living with 
elements of life that are difficult or challenging, 
incorporating compassion and non-judgment.  
 Alternate body scan 
and yoga daily  
 Sit 10 min daily 
with AOB 
 Arriving for rest: 
short body scan 
prior to sleep 
 Keep calendar of 
one pleasant 
event each day 
and how it is 
reflected in mind 
and body.  
3  
Relational 
presence: 
Mindfulness in 
dialogue with 
the body as a 
place to learn; 
offer 
hospitality to 
one’s 
experience 
 Sitting 
meditation 
 Yoga practice 
 Mindful 
dialogue 
 Physiological and psychological bases of stress 
reactivity are reviewed along with relevant 
mindfulness research.  
 Guidelines for mindful dialogue are introduced in 
greater depth and practiced: Pause, Relax, Open-
Allow. 
 Compassion as both attitude and behavior relating to 
self and others is highlighted as integral to and an 
outcome of practice.  
 Sitting meditation, 
yoga, or body 
scan daily 
 Keep daily 
Reactivity-
Responsivity 
Calendar as 
relates to 
communication 
4  
Mindful 
dialogue: 
Cultivating 
compassion & 
responsiveness 
in speech and 
action; 
communication 
on ACP as 
empowerment 
 Sitting 
meditation 
 Yoga practice 
 Mindful 
dialogue 
 Lovingkindness 
practice 
 Expansion of mindful speaking and listening 
guidelines allowing previously learned 
mindfulness practices to support patients and their 
family caregivers in non-habitual, non-reactive 
communication.  
 Mindful dialogue about present moment challenges 
related to 1) being with change and uncertainty, 
and 2) discussing goals of care with healthcare 
providers and family members. 
 Participants invited to open dialogue about what they 
value. 
 Participants are provided information about ACP, 
including the POST form52 and palliative care 
programs in the area. 
 Sitting meditation, 
yoga, body scan, 
or lovingkindness 
practice 
 Read ASCO 
Advanced Care 
Planning 
booklet77 and 
review POST 
form together in 
mindful dialogue.  
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5  
Mindful 
dialogue 
associated 
with 
challenging 
thoughts and 
feelings: 
Meeting with 
practice what 
impedes open 
communication  
 Sitting 
meditation 
 Yoga practice 
 Mindful 
dialogue 
 Lovingkindness 
practice 
 Using mindful dialogue guidelines, deeper discussion 
of ACP as an ongoing process shared by patients, 
their family members, and oncology providers 
grounded in the patient’s values and preferences 
for goals of care.  
 Benefits of making timely decisions about desired 
scope of treatment are highlighted, as well as 
consideration of surrogate decision-makers.  
 ACP tools, including the POST form, are further 
reviewed as a means of facilitating individual 
choices.  
 This dialogue honors the wide variance of beliefs and 
values in the room within the themes of the shared 
human experience of coping with the unpredictable 
nature of life’s changes and the preciousness of 
life.  
 Sitting meditation, 
yoga, or body 
scan with 
recorded 
guidance or self-
guidance daily. 
 Practicing mindful 
dialogue 
guidelines in 
everyday life. 
 Consider how to 
support ongoing 
practice and 
mindful dialogue 
after the class. 
6  
The rest of 
your life: 
Making the 
practice your 
own 
 Body scan 
 Yoga 
 Sitting 
meditation 
 Lovingkindness 
practice 
 Emphasis on the growing capacity of all participants 
to adapt more easily and effectively to everyday 
challenges and stressors, particularly those 
associated with advanced cancer.  
 Taking a mindful, open, conscious, and responsive—
rather than reactive—approach is emphasized.  
 Utilizing mindful communication skills, inviting each 
patient and family caregiver to share what has been 
learned in practice and any lingering questions 
concerning process and decisions about care 
preferences.  
 Invitation for patients to continue discussing care 
preferences with oncology team and sign POST 
form at next appointment with oncologist if ready 
to do so.  
 Review of core mindfulness skills and sharing of 
resources to support mindfulness practice after the 
class concludes. 
 Mindfulness 
resources handout 
 
Abbreviations: ACP, advance care planning; ASCO, American Society of Clinical Oncology; POST, Physician 
Orders for Scope of Treatment. 
 
aAll sessions were two hours and included provision of compact discs with audio recordings of guided meditations of 
body scan, sitting meditation, gentle hatha yoga, and lovingkindness meditation practices created by the facilitator for 
home practice. 
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Table 2.  Participant Demographics and Medical Characteristics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patien  
(n=13) 
FCG  
(n=13  
Age, mean (SD) 62.91 (10  56.58 (15  
Race, N (%)   
American Indian/Alaska Native 0 (0) 1 (7.69) 
Asian 0 (0) 1 (7.69) 
Black/African American 1 (7.69) 2 (15.38) 
White/Caucasian 12 (92.31  9 (69.23) 
Sex, N (%)   
Male 7 (53.85) 3 (23.08) 
Female 6 (46.15) 10 (76.92  
Education, N (%)   
High School/GED 2 (15.38) 1 (7.69) 
Technical/Trade School 1 (7.69) 1 (7.69) 
Some college 3 (23.08) 4 (30.77) 
Associate's Degree 0 (0) 3 (23.08) 
Bachelor's Degree 3 (23.08) 3 (23.08) 
Master's Degree 3 (23.08) 1 (7.69) 
Other 1 (7.69) 0 (0) 
Employment, N (%)   
Full-time 2 (15.38) 5 (38.46) 
Part-time 1 (7.69) 1 (7.69) 
Self-employed 1 (7.69) 1 (7.69) 
Unable to work 3 (23.08) 1 (7.69) 
Homemaker 0 (0) 2 (15.38) 
Retired 5 (38.46) 3 (23.08) 
Other 1 (7.69) 0 (0) 
Income, N (%)   
Comfortable 9 (69.23) 8 (61.54) 
Just enough to make ends meet 3 (23.08) 3 (23.08) 
Not enough to make ends meet 1 (7.69) 2 (15.38) 
Perception of Patient's Current Condition, N (    
Relatively healthy 4 (30.77) 4 (30.77) 
Seriously ill - not terminal 3 (23.08) 1 (7.69) 
Seriously ill - terminal 6 (46.15) 7 (53.85) 
Skipped 0 (0) 1 (7.69) 
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Table 3.  Intervention Satisfaction, Helpfulness, and Home Practice. 
 
Survey Item Response Scale Anchors 
Patients  
(N=11) 
FCGs  
(N=12)   
Mean SD Mean SD 
SATISFACTION 
     
Overall, how satisfied are you with your experience in the MODEL Care course? 
1 = Completely     
      dissatisfied 
7 = Completely 
      satisfied 
6.455 0.522 6.333 0.778 
HELPFULNESS OF MODEL CARE  
     
Becoming more aware of my thoughts, feelings, and bodily sensations 
1 = Not at all 
      helpful 
5 = Very helpful 
4.636 0.674 4.667 0.888 
Knowing that I am not alone in my experiences 4.818 0.405 4.667 0.651 
Learning how to live more in the present moment 4.545 0.522 4.833 0.577 
Coping with difficult thoughts, feelings, or bodily sensations 4.455 0.688 4.250 1.055 
Learning more about palliative care 4.182 0.751 3.750 1.138 
The CDs and printed materials I received helped me to practice. 
1 = Strongly 
      disagree 
5 = Strongly 
      agree 
4.545 0.522 4.500 0.522 
The CDs and printed materials were easy to understand. 4.727 0.467 4.917 0.289 
The session facilitator was "tuned in" to my needs. 4.545 0.688 4.833 0.577 
Being involved in MODEL Care has made me feel anxious 1.909 1.221 1.583 0.900 
Being involved in MODEL Care has made it more difficult to deal with thoughts of cancer. 1.364 0.505 1.417 0.515 
How likely are you to recommend the MODEL Care course to a friend or family member in a 
similar situation as you?   
1 = Extremely 
      unlikely  
5 = Extremely 
      likely 
4.636 0.505 4.750 0.452 
How likely are you to continue to use what you learned in the MODEL Care course? 4.545 0.522 4.667 0.651 
HOME PRACTICE HABITS 
     
Reported at T2 
0-7 days 
    
How many days per week, on average, have you participated in FORMAL mindfulness 
practice during the MODEL Care course? 3.545 1.635 3.333 1.435 
How many days per week, on average, have you participated in INFORMAL mindfulness 
practice during the MODEL Care course? 5.182 1.991 5.000 1.706 
Reported at T3     
23 
 
How many days per week, on average, have you participated in FORMAL mindfulness 
practice since completing the MODEL Care course last month? 3.000 2.049 2.917 1.782 
How many days per week, on average, have you participated in INFORMAL mindfulness 
practice since completing the MODEL Care course last month? 5.000 1.549 4.083 1.564 
 
Note. SD=standard deviation. All items were asked at T2, except where indicated. FORMAL mindfulness practice includes the body scan, sitting meditation, 
compassion meditation, and mindful movement featuring gentle hatha yoga with chair adaptations. INFORMAL mindfulness practice refers to bringing  
present-moment awareness to everyday activities (e.g., eating a meal, brushing teeth, washing dishes).  
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Table 4.  Patient and Family Caregiver Outcomes. 
 
Possible 
Score 
Range1 
T1  
Mean 
(SD)2 
T2 
Mean 
(SD) 
T3 
Mean 
(SD) 
T1 - T2  
SRM 
(95% CI) 
p-value 
T1 - T3  
SRM 
(95% CI) 
p-value 
Patient Outcomes 
Distress  
      Depression  
      (PHQ-8) 0-24 
7.91 
(4.44) 
5.36 
(5.14) 
4.18 
(4.62) 
-0.91 
(-1.58, -0.24)* 
.0131 
-1.38 
(-2.05, -0.71)* 
.0010 
      Anxiety  
      (GAD-7) 0-21 
4.27 
(3.47) 
2.09 
(2.34) 
2.18 
(2.60) 
-0.49 
(-1.16, 0.18) 
.1346 
-0.83 
(-1.51, -0.16)* 
.0199 
Other Symptoms  
      Sleep Disturbance  
      (PSQI) 0-3 
1.18 
(0.75) 
0.82 
(0.75) 
0.64 
(0.81) 
-0.54 
(-1.22, 0.13) 
.1039 
-0.79 
(-1.47, -0.12)* 
.0251 
      Fatigue Interference  
      (FSI) 0-10 
4.48 
(2.73) 
4.51 
(3.23) 
4.40 
(3.47) 
0.01 
(-0.65, 0.68) 
.9672 
-0.21 
(-0.88, 0.47) 
.5107 
Coping  
      Cognitive Avoidance  
      (Mini-MAC) 1-4 
2.64 
(0.53) 
2.20 
(0.89) 
2.25 
(0.81) 
-0.64 
(-1.31, 0.03) 
.0588 
-0.26 
(-0.93, 0.41) 
.4062 
      Self-Distraction  
      (Brief COPE) 1-4 
2.45 
(0.69) 
2.50 
(1.00) 
1.86 
(1.00) 
0.04 
(-0.63, 0.72) 
.8845 
-0.91 
(-1.58, -0.24)* 
.0131 
      Denial  
      (Brief COPE) 1-4 
1.05 
(0.15) 
1.09 
(0.30) 
1.09 
(0.30) 
0.30 
(-0.37, 0.97) 
.3409 
0.30 
(-0.37, 0.97) 
.3409 
      Behavioral Disengagement  
      (Brief COPE) 1-4 
1.27 
(0.41) 
1.09 
(0.30) 
1.05 
(0.15) 
-0.54 
(-1.21, 0.13) 
.1039 
-0.79 
(-1.46, -0.11)* 
.0261 
Quality of Life  
(McGill Overall) 0-10 
6.73 
(1.74) 
7.73 
(2.49) 
8.09 
(1.30) 
0.49 
(-0.18, 1.16) 
.1367 
0.95 
(0.28, 1.62)* 
.0102 
Family Communication  
(ODCNF) 1-4 
2.92 
(0.50) 
3.00 
(0.43) 
3.09 
(0.48) 
0.17 
(-0.50, 0.85) 
.5746 
0.33 
(-0.35, 1.00) 
.3053 
Family Caregiver Outcomes 
Distress  
      Depression  
      (PHQ-8) 0-24 
3.75 
(3.82) 
2.58 
(2.02) 
3.00 
(3.63) 
-0.37 
(-1.00, 0.27) 
.2308 
-0.22 
(-0.89, 0.45) 
.4825 
      Anxiety  
      (GAD-7) 0-21 
3.25 
(3.33) 
1.58 
(2.02) 
1.58 
(2.07) 
-0.58 
(-1.22, 0.05) 
.0695 
-0.49 
(-1.13, 0.14) 
.1169 
Other Symptoms  
      Sleep Disturbance  
      (PSQI) 0-3 
1.25 
(0.87) 
1.08 
(0.79) 
0.80 
(0.79) 
-0.18 
(-0.81, 0.46) 
.5505 
-0.71 
(-1.42, 0.01) 
.0522 
      Fatigue Interference  0-10 2.56 1.44 2.42 -0.56 0.01 
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      (FSI) (2.26) (1.62) (2.55) (-1.19, 0.08) 
.0790 
(-0.67, 0.68) 
.9829 
Coping  
      Cognitive Avoidance  
      (Mini-MAC) 1-4 
2.06 
(0.70) 
1.63 
(0.57) 
1.31 
(0.36) 
-0.53 
(-1.16, 0.11) 
.0939 
-1.05 
(-1.68, -0.41)* 
.0039 
      Self-Distraction  
      (Brief COPE) 1-4 
2.04 
(108) 
1.79 
(0.84) 
1.58 
(0.56) 
-0.27 
(-0.91, 0.36) 
.3653 
-0.45 
(-1.09, 0.18) 
.1444 
      Denial  
      (Brief COPE) 1-4 
1.04 
(0.14) 
1.08 
(0.19) 
1.17 
(0.58) 
0.29 
(-0.35, 0.92) 
.3388 
0.21 
(-0.43, 0.84) 
.4910 
      Behavioral Disengagement  
      (Brief COPE) 1-4 
1.21 
(0.5) 
1.04 
(0.14) 
1.04 
(0.14) 
-0.38 
(-1.01, 0.26) 
.2199 
-0.38 
(-1.01, 0.26) 
.2199 
Quality of Life  
(CQoLI-C) 0-4 
2.69 
(0.70) 
3.00 
(0.50) 
3.06 
(0.53) 
0.85 
(0.21, 1.48)* 
.0136 
1.02 
(0.35, 1.69)* 
.0070 
Family Communication  
(ODCNF) 1-4 
2.83 
(0.76) 
3.20 
(0.68) 
3.38 
(0.55) 
0.88 
(0.24, 1.52)* 
.0110 
0.80 
(0.12, 1.47)* 
.0249 
 
Notes. T1=baseline assessment; T2=post-intervention assessment; T3=1 month post-intervention assessment; 
SD=standard deviation; SRM=standardized response mean (0.2=small effect, 0.5=medium effect, 0.8=large effect);  
CI=confidence interval. 
1Higher scores on each outcome measure indicate more of the concept being measured. As such, lower scores on all 
outcomes are desirable, with the exception of the quality of life measures (McGill for patients and CQoLI-C for 
caregivers) and the family communication measure (ODCNF), wherein higher scores are desirable. 
2Mean (SD) at T1 is calculated for participants who had either T2 or T3 data.  
*p<.05. p-value from paired t-test test. 
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FIGURES 
Figure 1.  Consolidated Standards of Reporting Trials (CONSORT) flow chart, including number of participants 
assessed at each time point. 
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Figure 2.  Stages of change summary for patient advance care planning (ACP) behaviors from T1 to T3. 
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Figure 3.  Patients reporting Action or Maintenance stages of change for advance care planning behaviors from T1 
to T3. 
 
 
 
 
 
 
 
 
 
 
